Investigating how a hormone affects salt-sensitive high blood pressure
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension
This study is exploring how a natural substance called Atrial Natriuretic Peptide (ANP) can help people with high blood pressure that gets worse with salt, by looking at how it helps the kidneys get rid of salt and keeps blood pressure in check, which could lead to better treatments for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10890137 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of Atrial Natriuretic Peptide (ANP) in managing salt-sensitive hypertension, a condition where blood pressure increases in response to salt intake. The study examines how ANP promotes salt excretion and reduces blood pressure, particularly looking at its effects on kidney function and mitochondrial health. By using animal models, the researchers aim to uncover the molecular mechanisms behind salt sensitivity and how ANP can potentially mitigate kidney damage and improve blood pressure control. The findings could lead to new therapeutic approaches for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with salt-sensitive hypertension who may benefit from improved blood pressure control.
Not a fit: Patients with hypertension that is not influenced by salt intake may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for patients with salt-sensitive hypertension, improving their blood pressure management and overall kidney health.
How similar studies have performed: Previous studies have shown promising results with similar approaches, indicating potential for significant advancements in treatment.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Ilatovskaya, Daria — Augusta University
- Study coordinator: Ilatovskaya, Daria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.